id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0313-0002,FDA,FDA-2007-N-0313,Maximizing the Public Health Benefit of Adverse Event Collection Throughout a Product's Marketed Life Cycle; Public Workshop - Transcript,Other,TR-Transcript,2008-07-21T04:00:00Z,2008,7,2008-07-21T04:00:00Z,,2008-08-15T01:39:26Z,,0,0,090000648068ae2e